Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Parabilis Medicines Inc | 0 | 6,412,780 | +6,412,780 | $0 | $175.52M | 15.95% | +$175.52M |
| Beam Therapeutics Inc.(BEAM) | 4,540,132 | 4,540,132 | 0 | $108.19M | $155.77M | 14.16% | +$47.58M |
| Rapport Therapeutics, Inc.(RAPP) | 3,728,738 | 3,728,738 | 0 | $116.67M | $155.38M | 14.12% | +$38.70M |
| Seaport Therapeutics Inc | 0 | 6,294,951 | +6,294,951 | $0 | $136.60M | 12.42% | +$136.60M |
| Erasca, Inc.(ERAS) | 7,091,557 | 7,091,557 | 0 | $114.74M | $129.92M | 11.81% | +$15.18M |
| Vir Biotechnology, Inc.(VIR) | 12,916,663 | 12,694,163 | -222,500 | $115.73M | $129.35M | 11.76% | +$13.62M |
| Maze Therapeutics, Inc.(MAZE) | 4,120,053 | 4,120,053 | 0 | $122.98M | $122.98M | 11.18% | $0 |
| Lyell Immunopharma, Inc.(LYEL) | 3,247,162 | 3,247,162 | 0 | $65.14M | $45.53M | 4.14% | -$19.61M |
| Generate Biomedicines, Inc.(GENB) | 1,944,426 | 1,944,426 | 0 | $24.31M | $32.80M | 2.98% | +$8.50M |
| 10x Genomics, Inc.CL A(TXG) | 217,834 | 217,834 | 0 | $4.62M | $8.35M | 0.76% | +$3.73M |
| Boundless Bio, Inc.(BOLD) | 0 | 2,694,095 | +2,694,095 | $0 | $6.74M | 0.61% | +$6.74M |
| Gossamer Bio, Inc.(GOSS) | 8,055,916 | 8,055,916 | 0 | $2.65M | $1.33M | 0.12% | -$1.32M |
| Q32 Bio Inc.(QTTB) | 320,482 | 0 | -320,482 | $2.06M | $0 | — | -$2.06M |